Investor Ideas Potcasts, Cannabis News and Stocks on the Move; Episode 442 (OTC: VSYM) (TSX: KHRN)
Delta, Kelowna, BC - July 17, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today's podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Investor Ideas Potcasts, Cannabis News and Stocks on the Move; Episode 442 (OTC: VSYM) (TSX: KHRN)
Today's podcast overview/transcript:
Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.
In today's podcast we look at a few public and private company announcements.
View Systems, Inc.'s (OTC: VSYM) Sannabis S.A.S. announced that they will meet today with students and faculty from the University of Cauca to implement their internship program established through a Collaboration Agreement # 25-32.8-010 with Sannabis' Taller Libre Community Association. University of Cauca was founded in 1827 as the University of Popayan and later changed name to Universidad del Cauca in 1884.
For more information on the University visit, http://www.unicauca.edu.co/portaleningles/about-us
This agreement with the University allows Sannabis to approach major food and medical corporations that want to enter the cannabis space but are limited by research.
The Internship Program will cover the following areas:
- Research projects on the medicinal properties of Sannabis products, application of the products, protocols for product certification, dosing protocol for diseases, and research that derives from the projects of companies that support this initiative. (Health Sciences Faculty).
- Research projects on the benefits of cosmetic products. (Faculty of Engineering)
- Research projects of social impacts, in the development of community proposals, derived from the process of cultivation, transformation, commercialization and application of products.
- Research, production and development projects in the process of , psychoactive (THC) and non-psychoactive (CBD) cultivation, cultivation for flower, seed, stems, and comprehensive use of cannabis (Faculty of Agricultural Sciences).
- Cannabis regulation. (Faculty of Law, political and social sciences)
Sannabis previously announced a site visit of their Seed Propagation Facility near
Popayan-CAUCA by the Colombian Institute of Agriculture (ICA) on July 30, 2020 at 9am. ICA will inspect, make recommendations, and give the Company 60 days to comply, after which the approval process begins. Sannabis applied for this license prior to December 31, 2018, the deadline for new applications, after this date no more applications are being accepted. Arguably a Colombian Seed Use License could be the most sought after and valuable marijuana license anywhere in the World.
The University of Cauca will certify Sannabis products as well as the Sannabis Cultivars from their seed bank. Students will also study the dosification and efficacy of Sannabis products giving the Company a huge advantage over competitors.
"I don't believe many Cannabis products on the shelves in the U.S. and elsewhere have been analyzed and certified by a 190-year-old University. Dosage has always been an issue with consumers since it's anecdotal and until now wasn't backed by research, right now it's trial and error to find the dosage that works for you," stated John Campo, President of View Systems, Inc. and Sannabis co-founder.
"We're proud to be working with the University in my hometown," stated Juan Paulo Guzman, co-founder and Director of Sannabis. "Several other much bigger companies were after this relationship and we're happy the University recognized our 23 years working with the community making quality products and promoting a new livelihood," continued Mr. Guzman.
Students will work with Sannabis' ongoing projects focusing on Medical and Social Components of Sannabis products and other initiatives that involve the integral use of cannabis, taking into account the aforementioned and being aware of the importance of each of the academic disciplines in all processes.
Sannabis has been working in Cauca, Colombia's top marijuana growing region for over 23 years, educating Indigenous tribes and locals on the health benefits of the legitimate use of marijuana. Cauca is home to landrace strains made famous by a documentary chronicling a futile attempt by a European seed bank to take these strains out of Colombia.
To view a timeline of Sannabis' 23-year history in Cauca, visit https://www.tallerlibre.org/historia
NuggMD, the nation's leading medical marijuana telemedicine platform, announced that it is now providing telemedicine services to patients in Ohio for $139.
Ohio normally prohibits the use of telemedicine for medical marijuana evaluations, but has lifted this restriction for the duration of the pandemic emergency orders. This makes it possible for patients to get their MMJ recommendation without risking exposure to Sars-COV-2.
"We're so excited to join Ohio's medical marijuana community," says Alex Milligan, NuggMD Co-Founder and CMO. "We hope that Ohio will see the benefit of allowing medical marijuana telemedicine services to continue for the long term. Even after the pandemic is over, and we don't know how long this will take, telemedicine is an incredibly valuable tool for at-risk patients."
"COVID-19 is forcing the medical community to re-consider their long-standing prejudices against telemedicine," says Kam Babazade, NuggMD Co-Founder and COO. "The misperception that patients can't receive the same quality of care and follow up via telemedicine has forced immunocompromised patients to risk exposure to illness in order to comply with local state laws. After the pandemic is over, these patients will face the same unnecessary risks to their health. We hope the state will consider making this change to their policy permanent for the well-being of at-risk cannabis patients across the state."
The state has not yet determined when the emergency orders for COVID-19 will be lifted. Recently, several states have seen a resurgence of the virus and have taken measures to increase social distancing again.
At the time this press release was written, Ohio had 46,970 confirmed cases of COVID-19, 7,681 hospitalizations and 2,807 total deaths. This total reflects a spike in confirmed cases over the final weekend of June. Those at the highest risk of contracting the virus are advised by authorities to remain at home as much as possible.
An Ohio medical marijuana evaluation with NuggMD costs just $139. As always, patients who are not approved for a medical marijuana recommendation receive their evaluation for free.
Since 2016, NuggMD has helped more than 600,000 patients connect face-to-face with their MMJ doctors via video telemedicine in California, New York, Nevada, Oklahoma and Missouri. NuggMD's practitioners provide medical marijuana recommendations to patients only in states for which they are fully-licensed to practice medicine. They are also approved to provide recommendations by their respective regulatory agencies where necessary.
Tidal Health Solutions Ltd., a privately held Licensed Producer (LP) and one of Canada's leading suppliers of Cannabis 2.0 products, announced that it is now supplying topical cannabis products in Canada.
"Our topical products are the result of extensive research and development and are leading the category in Canada", said Mark E. Burton, President and CEO of Tidal Health Solutions. "We are one of the few Licensed Producers providing these products".
Tidal's RIVA brand focuses on the benefits of cannabidiol (CBD) while the TULLIA brand features equal amounts of CBD and tetrahydrocannabinol (THC). Both come in 200mg and 400mg cannabinoids per jar formats. They are both fast absorbing lotions with a natural eucalyptus extract that provide a pleasant cooling sensation similar to a cool ocean breeze.
"In my clinical experience, well-developed topicals may be useful for conditions close to the skin's surface such as arthritis and neuropathic pain", said Dr. Douglas Smith, a founder of Tidal Health Solutions and a national expert in the medical use of cannabis. "They are very pleasant and easy to use".
The products are now available in Ontario, New Brunswick, Nova Scotia, Saskatchewan and will soon be available in Prince Edward Island and Alberta.
Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQX: KHRNF), a vertically integrated cannabis leader with core operations in Latin America and Europe, today announced that Alvaro Torres, Khiron CEO and Director will lead a live, on-camera virtual tour of the Company's recently completed 15,000 square foot Zerenia integrated medical facility located in Bogota, Colombia.
Date: Tuesday, July 21st
Tour start: 9:00am ET
Participants: Alvaro Torres, Khiron CEO and Director, together with popular Colombia broadcaster Jorge Hernan Pelaez
This will be the first in a series of live, interactive events present by Khiron. Attendees are invited to ask the Company questions in real time, learn about the clinic operational model, meet members of the medical team, and discuss the Zerenia health and wellbeing advantages, including operations during the Covid-19 recovery. An archived recording will be available after the event.
Recent Company Highlights:
- Becomes the first and, to date, only company fully authorized to manufacture and sell high-THC medical cannabis for patient prescriptions in Colombia
- Signs distribution deal for its Kuida™ CBD cosmeceutical brand with Red Yellow Red, a leading EU distributor of cosmetic products, bringing the Kuida brand to the Spanish market
- Enters into an agreement with Nimbus Health, a leading German distributor of medical cannabis products to bring Khiron branded EU GMP medical cannabis to Germany
- Receives first medical cannabis prescriptions for patients participating in the UK's Project Twenty21, Europe's largest study of the effectiveness and tolerability of medical cannabis
Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.
Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea's original branded content includes the following podcasts and columns: Crypto Corner, Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change, Exploring Mining the AI Eye.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Follow us on Cannabis Social Media
Download our Mobile App for iPhone and Android